Biomarker ID | 684 |
PMID | 21741162 |
Year | 2011 |
Biomarker | PVRL1 (poliovirus receptor-related 1); PRG4 (proteoglycan 4); AP (alkaline phosphatase); FSTL1 (follistatin-like 1); Albumin; CEACAM1 (carcinoembryonic antigen related cell adhesion molecule 1); ANPEP (alanyl (membrane) aminopeptidase); CRP (C-reactive protein); Hb (hemoglobin); CADM1a (cell adhesion molecule 1a); POSTN (periostin, osteoblast specific factor); CADM1b (cell adhesion molecule 1b); CP (ceruloplasmin); AZGP1 (alpha-2-glycoprotein 1, zinc-binding). |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include(PVRL1):- Nectin/Necl trans heterodimerization, Nectin adhesion pathway, Adherens junction actin cytoskeletal organization, Adherens junction cell adhesion, Cell junction organization Pathways Include(PRG4):- Integrin Pathway,ERK Signaling, Phospholipase-C Pathway Pathways Include(FSTL1):- Signaling by bone morphogenetic protein (BMP), Signal transduction Pathways Include(CP):-Vitamin B12 metabolism,Selenium pathway, Folate metabolism,Interleukin-6 signaling pathway,Complement cascade |
Experiment | Overall Survival Vs No Survival |
Type of Biomarker | Prognostic |
Cohort | 57 patients with prostate cancer were included in the study. At the time of the analysis, 65% of patients had died (n = 37); of these, 89% (n = 33) died from mCRPC. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | PVRL1 (poliovirus receptor-related 1) p= 0.002; CD10 p= 0.004; PRG4 (proteoglycan 4) p = 0.006; AP (alkaline phosphatase) p= 0.007; FSTL1 (follistatin-like 1) p= 0.01; Albumin p= 0.016; CEACAM1 (carcinoembryonic antigen related cell adhesion molecule 1) p = 0.018; ANPEP (alanyl (membrane) aminopeptidase) p=0.02; CRP (C-reactive protein) p= 0.02; Hb (hemoglobin) p=0.022; CADM1a (cell adhesion molecule 1a) p =0.03; POSTN (periostin, osteoblast specific factor) p=0.034; CADM1b (cell adhesion molecule 1b) p=0.035; CP (ceruloplasmin) p =0.046; AZGP1 (alpha-2-glycoprotein 1, zinc-binding) p =0.046. |
Method Used | ELISA + Mass Spectrometry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | PVRL1, PRG4, AP, FSTL1, Albumin, CEACAM1, ANPEP, CRP, Hb, CADM1a, POSTN, CADM1b, CP, AZGP1 |